Orchid Chemicals & Pharmaceuticals Ltd (Orchid) was established in 1992 as a 100% Export Oriented Unit (EOU). Commencing operations in 1994, Orchid has achieved amazing and consistent growth, quantitatively and qualitatively to emerge among the Top-15 companies in the Indian pharmaceutical industry in a short span of fourteen years of operations. Orchid employs over 4200 people, of which over 700 are scientists, technologists and other professionals.

Orchid's growth and positioning in the global pharmaceutical industry are indeed distinctive. A robust leadership position in the antibiotics space, a core competence in aseptic manufacture, a broad-based multi-therapeutic coverage and an end-to-end connectivity over the pharmaceutical value chain, from discovery to delivery, have positioned Orchid uniquely.

Orchid has two manufacturing sites for APIs (at Alathur near Chennai and at Aurangabad, near Mumbai) and three manufacturing sites for Dosage forms (at Irungattukottai and Alathur in Chennai), besides two R&D centres (at Sholinganallur and Irungattukottai, Chennai). Orchid’s facilities are state-of-the-art and have several international regulatory approvals, including the US FDA and UK MHRA. Orchid’s API facilities are ISO certified for their quality, environmental management and operational health and safety systems. Orchid has a Joint Venture in China for manufacturing sterile APIs.

Orchid’s scientific and technical strengths have made it a partner of choice for several multinational corporations. Orchid has long-term exclusive marketing alliances with reputed global companies for distribution of its products in the advanced markets.

Orchid has an established end-to-end connected infrastructure for drug discovery and development which are channeled through its subsidiaries, Orchid Research Laboratories in Chennai and Bexel Pharmaceuticals in the US. Through superior infrastructure and by adopting a judicious blend of structure-based drug design approach, Orchid has been able to simultaneously work on several therapeutic programs with several lead compounds in advanced stages of trials. Orchid has also entered into Contract Research initiatives with key multinational companies.

Orchid is a leader in the use of environment friendly technologies. Orchid has invested substantially in zero-discharge manufacturing processes at its facilities and is considered a national show-case in environmental friendliness.